Fortrea Holdings Inc. (FTRE) vs Immunome, Inc. (IMNM)
- Fortrea Holdings Inc. FTRE 22.49 −1.14%
- Immunome, Inc. IMNM 16.47 −5.34%
Fortrea Holdings Inc. and Immunome, Inc. are both Biotechnology companies. Fortrea Holdings Inc. and Immunome, Inc. are of similar size ($2.2B and $2.1B). Immunome, Inc. grew revenue faster over the last twelve months: 16.7% against −2.09%. Immunome, Inc. has the higher net margin (0.00% vs −3.18%) and the lower return on invested capital (−3,323.0% vs −0.48%). Across the 17 metrics below, Immunome, Inc. leads on 9 and Fortrea Holdings Inc. on 8.
Valuation
Profitability
| Metric | FTRE | IMNM | Biotechnology median |
|---|---|---|---|
| Gross margin | 19.30% | 100.00% | 65.16% |
| Operating margin | (0.40%) | 0.00% | 0.00% |
| Net margin | (3.18%) | 0.00% | 0.00% |
| Free cash flow margin | 7.40% | 0.00% | 0.00% |
| Return on equity | (15.30%) | (64.03%) | (56.36%) |
| Return on assets | (3.07%) | (59.03%) | (48.04%) |
| Return on invested capital | (0.48%) | (3,322.99%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack